Compare Stocks

→ REVEALED: Elon Musk’s Secret A.I. Facility? (From InvestorPlace) (Ad)

Compare stocks and their fundamentals, performance, price, and technicals. Use this free stock comparison tool to evaluate companies based on their analyst ratings, book value, debt, dividend, MarketRank, news sentiment, price performance, profitability, and more. Enter up to ten stock symbols separated by a comma or space (ex. BAC, JPM, WFC, C, GS).

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
AMDA Amedica	$0.02	$0.26	$0.18 ▼ $6.40	$260K	-1.24	1.07 million shs	21.92 million shs
APOP Cellect Biotechnology	$13.17 +0.4%	$11.51	$6.64 ▼ $35.52	$12.87M	1.87	479,845 shs	17,400 shs
ASNB EKIMAS	$0.61	$0.54	$0.55 ▼ $1.75	$3.54M	0.37	3,162 shs	1 shs
RGIN Regenicin	$0.01	$0.00	$0.00 ▼ $0.01	$829K	N/A	269,386 shs	N/A

20 Stocks to Sell Now

MarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio? Find out by clicking the link below.

Get This Free Report

Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
AMDA Amedica	0.00%	-4.44%	-81.04%	-92.82%	-98.65%
APOP Cellect Biotechnology	0.00%	0.00%	0.00%	0.00%	0.00%
ASNB EKIMAS	0.00%	0.00%	+1.67%	+1.67%	-18.67%
RGIN Regenicin	0.00%	+4,900.00%	+4,900.00%	+4,900.00%	+233.33%

“Forget Tesla, this is Elon’s Next Big Thing” (Ad)

According to Forbes, this breakthrough could define the future of AI. Most people don’t know about it… Because it was found 750 miles away from Silicon Valley.

Click here to see the details.

MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	Dividend Strength	ESG Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
AMDA Amedica	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
APOP Cellect Biotechnology	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
ASNB EKIMAS	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
RGIN Regenicin	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

Analyst Ratings

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
AMDA Amedica	N/A	N/A	N/A	N/A
APOP Cellect Biotechnology	N/A	N/A	N/A	N/A
ASNB EKIMAS	N/A	N/A	N/A	N/A
RGIN Regenicin	N/A	N/A	N/A	N/A

Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
AMDA Amedica	$11.23M	0.02	N/A	N/A	$1.80 per share	0.01
APOP Cellect Biotechnology	N/A	N/A	N/A	N/A	$4.77 per share	N/A
ASNB EKIMAS	N/A	N/A	N/A	N/A	$0.03 per share	N/A
RGIN Regenicin	N/A	N/A	N/A	N/A	($0.04) per share	N/A

Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
AMDA Amedica	-$9.32M	-$3.13	N/A	N/A	N/A	-139.62%	-148.60%	-67.83%	N/A
APOP Cellect Biotechnology	-$5.62M	N/A	0.00	∞	N/A	N/A	N/A	N/A	N/A
ASNB EKIMAS	-$290K	N/A	0.00	∞	N/A	N/A	-7,902.31%	-5,274.01%	N/A
RGIN Regenicin	-$640K	N/A	0.00	∞	N/A	N/A	N/A	N/A	N/A

Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
AMDA Amedica	N/A	N/A	N/A	N/A	N/A
APOP Cellect Biotechnology	N/A	N/A	N/A	N/A	N/A
ASNB EKIMAS	N/A	N/A	N/A	N/A	N/A
RGIN Regenicin	N/A	N/A	N/A	N/A	N/A

Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
AMDA Amedica	N/A	1.11	0.99
APOP Cellect Biotechnology	N/A	3.01	3.01
ASNB EKIMAS	N/A	0.12	0.12
RGIN Regenicin	N/A	N/A	N/A

Ownership

Institutional Ownership

Company	Institutional Ownership
AMDA Amedica	3.72%
APOP Cellect Biotechnology	4.84%
ASNB EKIMAS	N/A
RGIN Regenicin	0.01%

Insider Ownership

Company	Insider Ownership
AMDA Amedica	0.90%
APOP Cellect Biotechnology	N/A
ASNB EKIMAS	7.80%
RGIN Regenicin	N/A

Miscellaneous

Company	Employees	Shares Outstanding	Free Float	Optionable
AMDA Amedica	N/A	11.87 million	N/A	Not Optionable
APOP Cellect Biotechnology	2,020	977,000	N/A	Not Optionable
ASNB EKIMAS	11	5.80 million	5.35 million	Not Optionable
RGIN Regenicin	3	165.77 million	N/A	Not Optionable

APOP, RGIN, AMDA, and ASNB Headlines

Source	Headline
	Severe cold front hits central, eastern regions; schools forced to delay start of new semester globaltimes.cn - February 21 at 10:59 PM
	Palworld map – all locations, regions, and points of interest pcgamesn.com - February 2 at 10:38 AM
	Alexander boys fend off top challenger in Region 5 ajc.com - January 30 at 7:33 PM
	John Kerry praises Biden for preventing 'uncontrolled war in many regions' foxnews.com - January 20 at 12:10 AM
	Journal of the History of Economic Thought cambridge.org - January 7 at 7:36 AM
	History of computers: A brief timeline livescience.com - December 24 at 7:27 PM
	WATCH: Blue Origin successfully launches rocket in first flight since 2022 crash wlwt.com - December 21 at 3:37 PM
	Blue Origin successfully completes rocket mission more than a year after failed launch nydailynews.com - December 21 at 3:37 PM
	Blue Origin launches New Shepard rocket, aces landing in 1st return to flight since 2022 failure (video) space.com - December 20 at 5:23 PM
	Jeff Bezos’ Blue Origin puts a hold on its first suborbital space launch in 15 months geekwire.com - December 20 at 5:23 PM
	History of Walmart: Timeline and Facts thestreet.com - December 9 at 1:54 PM
	Region police calls – Nov. 28 therepublic.com - December 1 at 12:05 AM
	Air defenses destroy 11 Ukrainian drones over four Russian regions tass.com - November 27 at 10:05 PM
	New Regions Bank coming to Kingsport timesnews.net - November 21 at 6:09 PM
	Florida high school football playoffs: A look at 5 wide open regions in the state theledger.com - November 16 at 7:42 PM
	Florida high school football playoffs: A look at the 5 deepest regions in the state gainesville.com - November 13 at 7:55 AM
	The 12 Regions of China: Past and Present thediplomat.com - October 28 at 7:48 AM
	VHSL power ratings \| Green Run, Maury, Phoebus all lead their regions at midseason pilotonline.com - October 6 at 11:34 PM
	Turtle Shells Record Nuclear History scientificamerican.com - September 14 at 9:47 PM
	Drones target six regions in largest drone attack on Russian soil since start of war in Ukraine nbcbayarea.com - September 7 at 4:29 PM
	Nolensville Little League vs. Smithfield, Rhode Island: Little League World Series score, updates tennessean.com - September 6 at 5:21 AM
	Road Trip of the Regions education.com - September 4 at 4:37 PM
	Heavy rains trigger floods and landslides in India's Himalayan region, leaving at least 48 dead foxnews.com - August 22 at 6:41 PM
	Leveraging Urbanization in South Asia worldbank.org - July 21 at 12:23 AM

Top Headlines

4 Stocks to Buy Before the Fed Cuts Interest Rates
March 19, 2024 7:49 AM
View 4 Stocks to Buy Before the Fed Cuts Interest Rates
Buy the Dip in Paychex, Inc. for a Pay Check at Retirement
April 2, 2024 11:07 AM
View Buy the Dip in Paychex, Inc. for a Pay Check at Retirement
Oversold and Diverging, Chewy Stock is Ready to Rebound
March 22, 2024 6:10 AM
View Oversold and Diverging, Chewy Stock is Ready to Rebound
WD-40 Company Greases the Wheels of Growth and Profits
April 10, 2024 10:12 AM
View WD-40 Company Greases the Wheels of Growth and Profits
Walt Disney’s Proxy Tug of War Pulls Shares to 52-Week Highs
April 1, 2024 9:02 AM
View Walt Disney’s Proxy Tug of War Pulls Shares to 52-Week Highs

All Headlines

Company Descriptions

Amedica

NASDAQ:AMDA

SINTX Technologies, Inc. engages in the development and commercialization of silicon nitride for medical and non-medical applications. It markets spinal fusion products and develops products for use in total hip and knee joint replacements. The company was founded by Aaron A. Hofmann and Ashok C. Khandkar in 1996 and is headquartered in Salt Lake City, UT.

Cellect Biotechnology

NASDAQ:APOP

Cellect Biotechnology Ltd. engages in the provision of regenerative medicine. Its activities include development of regenerative medicine through the development of products facilitating immune stem cell selection. The company also develops innovative technology, which allows the default stem cells by dramatically reducing of complications existing in conventional selection methods. The company was founded by Kasbian Nuriel Chirich, Shai Yarkoni, and Nadir Askenasy on August 4, 1986 and is headquartered in Kfar Saba, Israel.

EKIMAS

OTCMKTS:ASNB

EKIMAS Corp. engages in the development of polymer materials, which provide characteristics in the design and development of medical devices. Its biomaterials are used in devices that are designed for treating a range of anatomical sites and disease states. The firm's products include ChronoFlex, ChronoSil, HydroMed, HydroThane, and PolyBlend. The company was founded in 1993 and is headquartered in Las Vegas, NV.

Regenicin

OTCMKTS:RGIN

Regenicin, Inc. focuses on developing and commercializing a technology of tissue-engineered skin substitutes. Its product portfolio includes NovaDerm, a multi-layered tissue-engineered living skin and cultured skin substitute product for the treatment of burns; and TempaDerm to treat smaller wound areas on patients, such as ulcers. The company products are used to restore the qualities of healthy human skin for use in the treatment of burns, chronic wounds, and various plastic surgery procedures. The company was formerly known as Windstar, Inc. and changed its name to Regenicin, Inc. in July 2010. Regenicin, Inc. was incorporated in 2007 and is headquartered in Little Falls, New Jersey.

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial